# EDGAR Filing Document

**Accession Number:** 0001944885
**File Stem:** 0001213900-26-041647
**Filing Date:** 2026-4
**Character Count:** 8704
**Document Hash:** 95387d1e1d506d71ccc1888020c02513
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-26-041647.hdr.sgml**: 20260408

**ACCESSION NUMBER**: 0001213900-26-041647

**CONFORMED SUBMISSION TYPE**: SCHEDULE 13D

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20260408

**DATE AS OF CHANGE**: 20260408

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Apollomics Inc.
- **CENTRAL INDEX KEY:** 0001944885
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 000000000
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-94041
- **FILM NUMBER:** 26849469

**BUSINESS ADDRESS:**
- **STREET 1:** 989 EAST HILLSDALE BLVD.
- **STREET 2:** STE 220
- **CITY:** FOSTER CITY
- **STATE:** CA
- **ZIP:** 94404
- **BUSINESS PHONE:** 1-650-209-4055

**MAIL ADDRESS:**
- **STREET 1:** 989 EAST HILLSDALE BLVD.
- **STREET 2:** STE 220
- **CITY:** FOSTER CITY
- **STATE:** CA
- **ZIP:** 94404
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Chen Yi-Kuei
- **CENTRAL INDEX KEY:** 0002115232

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D

**MAIL ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** 18 F., NO. 290, SEC. 2, WENHUA RD.
- **STREET 2:** BANQIAO DIST.
- **CITY:** NEW TAIPEI CITY
- **PROVINCE COUNTRY:** F5
- **ZIP:** 220029

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## SCHEDULE 13D

### Under the Securities Exchange Act of 1934

**Apollomics Inc.**

*(Name of Issuer)*

**Class A ordinary shares, par value $0.01 per share**

*(Title of Class of Securities)*

**—**

*(CUSIP Number)*

**Yi-Kuei Chen**<br>5/F-4, No. 89, Songren Rd., Xinyi Dist.<br>Taipei City F5 11073<br>886-2-7713 7952

*(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)*

**02/17/2026**

*(Date of Event Which Requires Filing of this Statement)*

| **CUSIP No.** | **—** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Yi-Kuei Chen** | Name of reporting person<br>**Yi-Kuei Chen** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**WC** | Source of funds (See Instructions)<br>**WC** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**F5** | Citizenship or place of organization<br>**F5** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**100.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**115071.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**100.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**115071.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**115071.00** | Aggregate amount beneficially owned by each reporting person<br>**115071.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**5.3%** | Percent of class represented by amount in Row (11)<br>**5.3%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**IN** | Type of Reporting Person (See Instructions)<br>**IN** | |

---

**Comment for Reporting Person:** (1) Rows 8, 10 and 11 include (i) 101,248 Shares held by Maxpro Investment Co., Ltd. ("Maxpro"), (ii) 3,823 Shares issuable upon exercise of warrants held by Maxpro that are exercisable within 60 days of the date of this Schedule 13D, and (iii) 10,000 restricted stock units representing the right to receive Shares held directly by Mr. Chen, consisting of 5,000 RSUs that vested on February 17, 2026 and 5,000 RSUs scheduled to vest on May 17, 2026 (which is within 60 days of the date of this Schedule 13D). The warrants and RSUs are included pursuant to Rule 13d-3(d)(1) as rights to acquire Shares within 60 days. RSUs do not provide shareholder voting rights prior to settlement/issuance of Shares.

**Item 1. Security and Issuer**

**(a) Title of Class of Securities:**
Class A ordinary shares, par value $0.01 per share

**(b) Name of Issuer:**
Apollomics Inc.

**(c) Address of Issuer's Principal Executive Offices:**
989 E. Hillsdale Blvd., Suite 220, Foster City, CA, 94404

**Item 4. Purpose of Transaction**

The Shares are held for investment purposes. Except as may occur in the ordinary course in the Reporting Person's capacity as an officer and director of the Issuer (including participating in discussions and decisions relating to the Issuer's operations, strategy, financing, and corporate governance), the Reporting Person does not currently have any plans or proposals that relate to or would result in any of the actions or transactions described in Items (a) through (j) of Item 4 of Schedule 13D. The Reporting Person may, from time to time, review the Reporting Person's investment in the Issuer on the basis of various factors, including the Issuer's business, financial condition, results of operations, prospects, and market conditions, and may in the future acquire additional Shares or dispose of some or all of the Shares, subject to applicable law and the Reporting Person's insider status.

**Item 5. Interest in Securities of the Issuer**

**(a)**
The Reporting Person beneficially owns 115,171 Shares, representing approximately 5.3% of such class of securities, consisting of (i) 100 Shares held directly by Mr. Chen, (ii) 101,248 Shares held by Maxpro, (iii) 3,823 Shares issuable upon exercise of warrants held by Maxpro that are exercisable within 60 days of the date of this Schedule 13D, and (iv) 10,000 restricted stock units representing the right to receive Shares held directly by Mr. Chen, consisting of 5,000 RSUs that vested on February 17, 2026 and 5,000 RSUs scheduled to vest on May 17, 2026 (which is within 60 days of the date of this Schedule 13D). Percentage ownership is based on 2,159,096 Shares outstanding as of March 31, 2026, as provided by the Issuer, and assumes the issuance of the 3,823 Shares issuable upon exercise of the warrants and the 10,000 Shares issuable upon settlement of RSUs that are deemed beneficially owned by the Reporting Person pursuant to Rule 13d-3(d)(1).

**(b)**
Mr. Chen exercises sole voting and dispositive power over the 100 Shares held by him directly. Mr. Chen exercises shared voting and dispositive power over the Shares held by Maxpro. In addition, as described in footnote (1) on the cover page and in Item 5(a), Rows 8, 10 and 11 include Shares issuable upon exercise of warrants held by Maxpro and Shares issuable upon settlement of RSUs held by Mr. Chen that are exercisable/settleable within 60 days; the RSUs do not provide shareholder voting rights prior to settlement/issuance of Shares.

**(c)**
The Reporting Person has not effected any transactions in the Shares during the past 60 days, except for the vesting of 5,000 RSUs on February 17, 2026 and as otherwise described herein.

**Item 6. Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer.**

Other than (i) the RSUs described in Items 3 and 5, (ii) the warrants held by Maxpro described in Item 5, and (iii) the Reporting Person's authority with respect to voting and disposition of the Shares held by Maxpro, there are no contracts, arrangements, understandings or relationships (legal or otherwise) between the Reporting Person and any other person with respect to any securities of the Issuer, including, but not limited to, transfer or voting of any of the securities of the Issuer, finder's fees, joint ventures, loan or option arrangements, puts or calls, guarantees of profits, division of profits or loss, or the giving or withholding of proxies.

### SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Yi-Kuei Chen

**Signature:** /s/ Yi-Kuei Chen

**Name/Title:** Yi-Kuei Chen

**Date:** 04/08/2026